Volume | 50,196 |
|
|||||
News | - | ||||||
Day High | 0.9999 | Low High |
|||||
Day Low | 0.8502 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Lexaria Bioscience Corporation | LEXX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.8502 | 0.8502 | 0.9999 | 0.9999 | 0.97 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
149 | 50,196 | $ 0.9314662 | $ 46,756 | - | 0.6488 - 3.5953 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:00 | 97 | $ 0.9902 | USD |
Lexaria Bioscience Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
8.09M | 8.09M | - | 384k | -4.23M | 0.00 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Lexaria Bioscience News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LEXX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.905 | 1.00 | 0.8502 | 0.9487222 | 34,891 | 0.0949 | 10.49% |
1 Month | 1.02 | 1.0568 | 0.844 | 0.927276 | 50,929 | -0.0201 | -1.97% |
3 Months | 0.72 | 1.1971 | 0.72 | 0.9132047 | 92,130 | 0.2799 | 38.88% |
6 Months | 2.587 | 2.78 | 0.6488 | 0.8924465 | 120,127 | -1.59 | -61.35% |
1 Year | 2.48 | 3.5953 | 0.6488 | 1.15 | 70,390 | -1.48 | -59.68% |
3 Years | 4.05 | 12.50 | 0.6488 | 5.67 | 364,492 | -3.05 | -75.31% |
5 Years | 4.05 | 12.50 | 0.6488 | 5.67 | 364,492 | -3.05 | -75.31% |
Lexaria Bioscience Description
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio. |